18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.

C Ma,X Wang,M Shao,L Zhao,X Jiawei,Z Wu,H Wang
2015-01-01
Abstract:Aim. Aim of the present study was to investigate the usefulness of F-18-FDG SPECT/CT in differentiated thyroid cancer (DTC) with elevated serum thyroglobulin (Tg) but negative iodine-131 scan. Methods. This retrospective review of patients with DTC recurrence who had F-18-FDG SPECT/CT and F-18-FDG PET/CT for elevated serum Tg but negative iodine-131 scan (March 2007-October 2012). After total thyroidectomy followed by radioiodine ablation, 86 consecutive patients with elevated Tg levels underwent F-18-FDG SPECT/CT or F-18-FDG PET/CT. Of these, 45 patients had F-18-FDG SPECT/CT, the other 41 patients had F-18-FDG PET/CT 3-4weeks after thyroid hormone withdrawal. The results of F-18-FDG PET/CT and SPECT/CT were correlated with patient follow-up information, which included the results from subsequent imaging modalities such as neck ultrasound, MRI and CT, Tg levels, and histologic examination of surgical specimens. The diagnostic accuracy of the two imaging modalities was evaluated. Results. In F-18-FDG SPECT/CT scans, 24 (24/45) patients had positive findings, 22 true positive in 24 patients, false positive in 2 patients, true-negative and false-negative in 6, 15 patients, respectively. The overall sensitivity, specificity, and accuracy of F-18-FDG SPECT/CT were 59.5%, 75% and 62.2%, respectively. Twenty six patients had positive findings on F-18-FDG PET/CT scans, 23 true positive in 26 (26/41) patients, false positive in 3 patients, true-negative and false-negative in 9, 6 patients, respectively. The overall sensitivity, specificity, and accuracy of F-18-FDG PET/CT were 79.3%, 81.8% and 78.1%, respectively. Clinical management changed for 13 (29%) of 45 patients by F-18-FDG SPECT/CT, 14 (34%). of 41 patients by F-18-FDG PET/CT including surgery, radiation therapy, or multikinase inhibitor. Conclusion. Based on the retrospective analysis of 86 patients, F-18-FDG SPECT/CT has lower sensitivity in the diagnosis of DTC recurrence with elevated Tg and negative iodine-131scan to F-18-FDG PET/CT. The clinical application of FDG SPECT/CT is then limited and cannot replace PET/CT.
What problem does this paper attempt to address?